<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>风云药谈 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-18T20:24:07+08:00</updated>
  <subtitle>分享、交流、学习</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>国采中选与未中选结局（很意外）：外资篇</title>
    <updated>2020-12-18T18:39:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/7DGl2Aa44qanFke40jLMng</id>
    <link href="https://mp.weixin.qq.com/s/7DGl2Aa44qanFke40jLMng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保谈判即将揭晓，化药多中药少。</title>
    <updated>2020-12-16T23:43:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/b6n-r8HdfQW9g4xJT9y7VQ</id>
    <link href="https://mp.weixin.qq.com/s/b6n-r8HdfQW9g4xJT9y7VQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>4+7扩围周年盘点，省300亿，规模平均萎缩61%</title>
    <updated>2020-12-15T17:24:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/PN8EzZSXagYR1q7YT529dg</id>
    <link href="https://mp.weixin.qq.com/s/PN8EzZSXagYR1q7YT529dg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>独家：第四批集采报量与限价预测</title>
    <updated>2020-12-13T23:09:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/j0FeoUEXdUfyTxMTF1bLbA</id>
    <link href="https://mp.weixin.qq.com/s/j0FeoUEXdUfyTxMTF1bLbA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>江苏“带量采”很快启动，规则基本清晰！</title>
    <updated>2020-12-11T19:50:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/N_Sk7GBra-KKqXSw_79SWw</id>
    <link href="https://mp.weixin.qq.com/s/N_Sk7GBra-KKqXSw_79SWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批国采深度分析（300亿规模、产品、企业），收藏！</title>
    <updated>2020-12-10T16:24:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/Z4RPmcnSU1RE5gfgZb9F0Q</id>
    <link href="https://mp.weixin.qq.com/s/Z4RPmcnSU1RE5gfgZb9F0Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批国采开始报量，44产品、90品规，附产品名单。</title>
    <updated>2020-12-09T12:42:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/WJFm6rzicr4ywDS3p2QIMA</id>
    <link href="https://mp.weixin.qq.com/s/WJFm6rzicr4ywDS3p2QIMA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年集采加速，国采符合产品已达78个！</title>
    <updated>2020-12-08T18:35:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/XxT0UYtnzB3G8q4TzK0DAw</id>
    <link href="https://mp.weixin.qq.com/s/XxT0UYtnzB3G8q4TzK0DAw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药代表最值得关注的7个公众号！</title>
    <updated>2020-12-08T18:35:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/VukksGdoKrlay_u0vGiutQ</id>
    <link href="https://mp.weixin.qq.com/s/VukksGdoKrlay_u0vGiutQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国采3进2，代理商的好机会？</title>
    <updated>2020-12-07T18:07:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/HReRpyxTwKBQJUAheiHLDw</id>
    <link href="https://mp.weixin.qq.com/s/HReRpyxTwKBQJUAheiHLDw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>压死未中标产品的“最后一根稻草”，结余留用执行！</title>
    <updated>2020-12-05T17:35:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/dWulTZqFz7m12ks7YEzvLQ</id>
    <link href="https://mp.weixin.qq.com/s/dWulTZqFz7m12ks7YEzvLQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>